Cargando…

Acute Care Use by Breast Cancer Patients on Adjuvant Chemotherapy in Alberta: Demonstrating the Importance of Measurement to Improving Quality

Breast cancer patients receiving adjuvant chemotherapy are at increased risk of acute care use. The incidence of emergency department (ED) visits and hospitalizations (H) have been characterized in other provinces but never in Alberta. We conducted a retrospective population-based cohort study using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Che Hsuan David, Quan, May Lynn, Kong, Shiying, Xu, Yuan, Cao, Jeffrey Q., Lupichuk, Sasha, Barbera, Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628700/ https://www.ncbi.nlm.nih.gov/pubmed/34898555 http://dx.doi.org/10.3390/curroncol28060375

Ejemplares similares

Four Cycles of Docetaxel-Cyclophosphamide versus Anthracycline-Taxane as Adjuvant Chemotherapy for HER2-Negative, Axillary Lymph Node Negative Breast Cancer: A Real-World Comparison of Alberta Patients Treated 2008–2012
por: Hannouf, Malek, et al.
Publicado: (2021)

Developing a Prediction Model for Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Model Building Approaches
por: Basmadjian, Robert B., et al.
Publicado: (2022)

First-Line Treatment with a Cyclin-Dependent Kinase 4/6 Inhibitor Plus an Aromatase Inhibitor for Metastatic Breast Cancer in Alberta
por: Amaro, Carla P., et al.
Publicado: (2021)

New method for determining breast cancer recurrence-free survival using routinely collected real-world health data
por: Jung, Hyunmin, et al.
Publicado: (2022)

Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study
por: Batra, Atul, et al.
Publicado: (2020)

Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
por: Al-Rashdan, Abdulla, et al.
Publicado: (2021)

Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis
por: Rigo, Rodrigo, et al.
Publicado: (2021)

Importance of quality in breast cancer screening practice – a natural experiment in Alberta, Canada
por: Yuan, Yan, et al.
Publicado: (2020)

Pertuzumab and Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor-2–Positive Metastatic Breast Cancer: Contemporary Population-Based Outcomes
por: Lupichuk, Sasha, et al.
Publicado: (2019)

141: Radiotherapy Decision Making in a Pandemic: Alberta’s Experience During the First Wave of COVID-19
por: Quirk, Sarah, et al.
Publicado: (2021)

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis
por: Breadner, Daniel, et al.
Publicado: (2022)

The Best of Alberta /
Publicado: (1987)

Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)
por: Chen, Yiqun, et al.
Publicado: (2009)

The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
por: Basmadjian, Robert B., et al.
Publicado: (2023)

Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013)

Meeting case investigation and contact tracing needs during COVID-19 in Alberta: the development and implementation of the Alberta Health Services Pod Partnership Model
por: Johnston, J. Cyne, et al.
Publicado: (2022)

The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
por: Smith, S. R., et al.
Publicado: (1982)

Survival in Women with De Novo Metastatic Breast Cancer: A Comparison of Real-World Evidence from a Publicly-Funded Canadian Province and the United States by Insurance Status
por: Savard, Marie-France, et al.
Publicado: (2022)

Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer
por: Chen, Kabytto, et al.
Publicado: (2022)

Impact of adjuvant chemotherapy for gliomatosis cerebri
por: Kong, Doo-Sik, et al.
Publicado: (2010)

The Importance of Demonstratively Restoring Order
por: Keizer, Kees, et al.
Publicado: (2013)

The importance of eating patterns for health-related quality of life among children aged 10–11 years in Alberta of Canada
por: Wu, Xiu Yun, et al.
Publicado: (2022)

Flora of Alberta : a manual of flowering plants, conifers, ferns, and fern allies found growing without cultivation in the Province of Alberta, Canada /
por: Moss, E. H. (Ezra Henry), 1892-1963
Publicado: (1959)

A Review of Trastuzumab Biosimilars in Early Breast Cancer and Real World Outcomes of Neoadjuvant MYL-1401O versus Reference Trastuzumab
por: Yang, Charlie, et al.
Publicado: (2022)

Testing a modified electronic version of the Edmonton symptom assessment system-revised for remote online completion with ambulatory cancer patients in Alberta, Canada
por: Watson, Linda, et al.
Publicado: (2023)

Locoregional Management of Breast Cancer: A Chronological Review
por: Al-Rashdan, Abdulla, et al.
Publicado: (2022)

Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
por: McFerrin, Coleman, et al.
Publicado: (2020)

Adjuvant chemotherapy for colorectal cancer
por: Maughan, T S
Publicado: (2001)

Exploring the Alberta Health Services COVID-19 provincial public health integrated outbreak prevention, preparedness, management, and response interventions to support congregate and communal living sites in Alberta
por: Loitz, Christina C., et al.
Publicado: (2023)

Assessing the impact of COVID-19 pandemic on the health of residents and the healthcare system in Alberta, Canada: an observational study—The Alberta POST-COVID Follow-up Study
por: Chen, Xueyi, et al.
Publicado: (2023)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
por: Lin, Hao, et al.
Publicado: (2021)

International Conference held at the University of Alberta
por: Freedman, Herbert, et al.
Publicado: (1983)

Overview of the Alberta Kidney Disease Network
por: Hemmelgarn, Brenda R, et al.
Publicado: (2009)

Development and assessment of the Alberta Context Tool
por: Estabrooks, Carole A, et al.
Publicado: (2009)

Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer
por: Grassadonia, Antonino, et al.
Publicado: (2022)

Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy
por: Otsuka, I, et al.
Publicado: (2002)

Impacts of Alternative Billing Claims on Hypertension Prevalence and Mortality Estimates in Alberta, Canada
por: Cunningham, Ceara Tess, et al.
Publicado: (2017)

Developments in asthma incidence and prevalence in Alberta between 1995 and 2015
por: Bosonea, Ana-Maria, et al.
Publicado: (2020)

Excess deaths during the COVID-19 pandemic in Alberta, Canada
por: Beesoon, Sanjay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp15ejn84ln9jmud3dmfv4rjla